Site navigation

Navigation

Hypercholesterolaemia - ezetimibe

Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia

Summary

Ezetimibe is recommended as a possible treatment for adults with primary (heterozygous-familial and non-familial) hypercholesterolaemia in the following circumstances. Ezetimibe can be taken on its own by a person who would normally be given a statin to treat their condition but can't because th ...

Read the complete summary


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in August 2010

About this guidance

Technology appraisals TA132

Issued: November 2007

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance